MediWhale, the South Korean health AI company behind the Dr. Noon platform, is presenting four cardiovascular disease studies at the American Heart Association's Scientific Sessions 2026, according to MEDI:GATE NEWS. The company announced the presentations on Monday, November 9, 2026.
MEDI:GATE NEWS reports that the four studies cover retinal imaging, coronary artery calcification, sleep apnea, biobank data, cardiac CT and stroke. The work draws on the Dr. Noon cardiovascular disease research program. The outlet's summary lists artificial intelligence and CT among the topics tied to the presentations.
The American Heart Association's Scientific Sessions is a major annual gathering for cardiovascular research, which gives MediWhale a prominent venue to present its Dr. Noon findings. The company's research links retinal image analysis with cardiovascular risk assessment, according to the topics named in the report.
The reporting does not include study results, author names or presentation dates, so the substance of the four abstracts remains to be seen. Watch for the full findings once the sessions take place and for any peer-reviewed publication that follows.
